Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novartis AG ADR (NVS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novartis ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
85.28 +0.45    +0.53%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
85.60
+0.32
+0.38%
19:00:00 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US66987V1098 
CUSIP:  66987V109
  • Volume: 2,114,535
  • Bid/Ask: 85.30 / 85.60
  • Day's Range: 84.69 - 85.97
Novartis ADR 85.28 +0.45 +0.53%
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Revenue 12814 13522 13367 13294
Revenue 12814 13522 13367 13294
Other Revenue, Total - - - -
Cost of Revenue, Total 3755 4000 3848 3754
Gross Profit 9059 9522 9519 9540
Total Operating Expenses 9962 10960 10134 9815
Selling/General/Admin. Expenses, Total 3498 3984 3601 3710
Research & Development 2256 2369 2261 2284
Depreciation / Amortization 35 30 25 27
Interest Expense (Income) - Net Operating 102 12 -9 60
Unusual Expense (Income) 193 307 312 -136
Other Operating Expenses, Total 123 258 96 116
Operating Income 2852 2562 3233 3479
Interest Income (Expense), Net Non-Operating -203 14415 21 38
Gain (Loss) on Sale of Assets - - - -
Other, Net 20 -26 -24 -11
Net Income Before Taxes 2669 16951 3230 3506
Provision for Income Taxes 450 645 472 611
Net Income After Taxes 2219 16306 2758 2895
Minority Interest 3 2 - 1
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2222 16308 2758 2896
Total Extraordinary Items - - - -
Net Income 2222 16308 2758 2896
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 2222 16308 2758 2896
Dilution Adjustment - - - -
Diluted Net Income 2222 16308 2758 2896
Diluted Weighted Average Shares 2237 2257 2254 2243
Diluted EPS Excluding Extraordinary Items 0.99 7.23 1.22 1.29
DPS - Common Stock Primary Issue - 3.2 - -
Diluted Normalized EPS 1.07 7.36 1.34 1.24
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVS Comments

Write your thoughts about Novartis AG ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Zoran Labus
Zoran Labus Mar 25, 2021 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Pankaj Negi
Pankaj Negi Jan 20, 2021 1:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
Pete Pete
Pete Pete Sep 30, 2020 12:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stats con chris
stats con chris Jun 17, 2020 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just to know. I'm lost.this is the company that bought the medicines company?
Kristof Mouton
Stoffel Sep 17, 2019 4:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
before investing in @novartis, read #teampia (twitter).
Kas Kas
Kast Feb 07, 2019 2:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
154952291883003.jpg
sell 89 expecting 80 timeframe 5 days
Robin Hood
Robin Hood Sep 28, 2018 7:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Long ENDOCYTE... I work in the field
Episcopolian OptionTrader
Episcopolian1 Jul 19, 2017 11:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$NVS: Novartis AG Looking at All Options Including IPO for Alcon Unit.. This is HUGE catalyst for $NVS share holders!!!!!
Episcopolian OptionTrader
Episcopolian1 Jul 10, 2017 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy this stock tomorrow as will be halted all day on Wednesday!
Episcopolian OptionTrader
Episcopolian1 Jul 07, 2017 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am willing to bet that FDA advisory committee WILL recommend their CTL019 drug!Post
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email